Company Filing History:
Years Active: 2010
Title: Sine Larsen – An Innovator in Dipeptidyl Peptidase I Research
Introduction
Sine Larsen, an accomplished inventor based in Hørsholm, Denmark, has made significant contributions to the field of biochemistry through her innovative research. With a keen focus on dipeptidyl peptidase I (DPPI), Sine has developed a patent that not only enhances our understanding of DPPI proteins but also opens new avenues for therapeutic applications.
Latest Patents
Sine Larsen holds a patent titled "Dipeptidyl peptidase I crystal structure and its uses." This patent encompasses detailed structural studies of DPPI proteins, modified versions, and various co-complexes. A notable highlight of her invention is the crystal structure of DPPI, along with essential structural information acquired via X-ray crystallography from both rat and human sources. Moreover, her work includes methods for utilizing the structure coordinates of DPPI and its mutants to create compounds that can effectively bind to the active site or accessory binding sites of DPPI, paving the way for improved inhibitors of this enzyme and its homologues.
Career Highlights
Sine Larsen's career is marked by her dedication to research and innovation in enzymology and structural biology. Her groundbreaking work in DPPI has positioned her as a respected figure in the scientific community, particularly within the realms of protein structure and drug design.
Collaborations
Sine has collaborated with esteemed colleagues Johan Olsen and Anders Kadziola, further expanding the impact of her research. These collaborations have fostered an environment of shared knowledge and expertise, facilitating advancements in the understanding and application of DPPI proteins.
Conclusion
Sine Larsen's innovative contributions through her patent on dipeptidyl peptidase I underscore her role as a pivotal inventor in her field. Her research not only enriches our scientific knowledge but also holds the potential for significant real-world applications, particularly in the development of new therapeutic strategies. Her work continues to inspire those in the blend of biochemistry and structural research.